Why CDMO Matters for Supplement Brands

At SREKE, we understand that supplement brand owners face a complex landscape: navigating formulation science, regulatory compliance, and market differentiation. The global nutraceutical contract manufacturing market was valued at $12.5 billion in 2023 and is projected to grow at 7.2% CAGR through 2030 (Grand View Research). Yet, many brand owners struggle with high MOQs, inconsistent quality, and long lead times from traditional OEM partners. CDMO—or Contract Development and Manufacturing Organization—bridges this gap by offering end-to-end services from R&D to commercial production. At SREKE, our CDMO model integrates formulation innovation, stability testing, and GMP-certified manufacturing under one roof, reducing time-to-market by up to 40% compared to fragmented supplier networks.

For procurement managers, the decision to partner with a CDMO like SREKE means accessing expertise in dosage form optimization—whether softgels, capsules, tablets, powders, gummies, or liquids—while ensuring compliance with FDA 21 CFR 111 and EFSA guidelines. Our clients tell us that the single biggest challenge is finding a partner that can handle both small-batch pilot runs and scalable production without compromising quality. That’s exactly what we deliver.

Key Manufacturing Considerations

Formulation and Dosage Forms

At SREKE, we specialize in developing custom formulations that meet specific bioavailability, stability, and delivery requirements. Our R&D team uses advanced techniques like hot-melt extrusion for enhanced solubility and microencapsulation for controlled release. We recommend conducting accelerated stability studies (40°C/75% RH for 6 months) to ensure product integrity across shelf life. For dosage forms, we offer softgels with oxygen-barrier shells, tablets with enteric coatings, and gummies with sugar-free options—all tailored to your brand’s target market.

Quality Standards and Certifications

Our facility holds GMP certification (ISO 22716 and 21 CFR 111), ISO 22000 for food safety, and HACCP certification. Every batch undergoes in-house testing for identity, potency, heavy metals (ICP-MS), microbial limits, and stability. We provide a Certificate of Analysis (COA) with every shipment, and we encourage third-party testing by ISO 17025-accredited labs for added credibility. For US market entry, we ensure compliance with FDA dietary supplement cGMPs, including NDI notifications where applicable.

Regulatory Compliance

We guide our clients through label claims that meet FDA structure-function guidelines (e.g., "supports immune health") and avoid disease claims. For EU markets, we align with EFSA’s health claim regulations and Novel Food requirements. Our regulatory team reviews all marketing materials to ensure adherence to 21 CFR 101.93 and provides documentation for customs clearance.

How to Choose the Right OEM Partner

What to Look For

• End-to-end capabilities: A CDMO that offers R&D, scale-up, packaging, and logistics—like SREKE—reduces your vendor management burden.
• Flexible MOQs: We work with MOQs as low as 10,000 units for pilot runs, scaling to millions for commercial orders.
• Transparent communication: We assign a dedicated project manager who provides weekly updates and a real-time production dashboard.
• Certifications: Verify GMP, ISO 22000, and HACCP certificates. Ask for audit reports.

Red Flags to Avoid

• Vague responses about ingredient sourcing or testing protocols.
• Inability to provide a full COA or stability data.
• Excessive minimum order quantities (over 100,000 units) without pilot options.
• No clear regulatory support for your target market.

Questions to Ask Before Placing an Order

• What is your typical lead time for formulation development and production?
• Can you provide a breakdown of costs—formulation, raw materials, packaging, and shipping?
• What third-party certifications do you hold, and can we audit your facility?
• How do you handle proprietary blends and IP protection?

Industry Trends and Market Opportunities

The global nutraceutical market is expected to reach $722 billion by 2027 (Mordor Intelligence), driven by demand for personalized nutrition, functional foods, and plant-based supplements. At SREKE, we see three key trends shaping OEM decisions:

• Personalization: Brands are seeking small-batch, custom formulations targeting specific demographics (e.g., women over 40, athletes). Our flexible production lines accommodate runs as small as 5,000 units.
• Clean labels: Consumers demand transparency. We offer organic, non-GMO, and allergen-free options with full traceability from farm to finished product.
• Sustainability: We use eco-friendly packaging (PCR bottles, compostable pouches) and energy-efficient manufacturing to reduce carbon footprint—a growing priority for B2B buyers.

To stand out, we recommend investing in unique delivery systems like fast-dissolving tablets or probiotic gummies with shelf-stable strains. Our R&D team can help you patent-pending formulations that create a defensible market position.

Frequently Asked Questions

What is the difference between a CDMO and a traditional OEM in nutraceuticals?

At SREKE, we explain that a CDMO offers integrated development services—formulation design, stability testing, and regulatory support—beyond just manufacturing. Traditional OEMs often only replicate existing formulas. With our CDMO model, you get a true partnership that accelerates innovation and reduces risk.

How long does it take to develop a private label supplement with SREKE?

Our typical timeline is 8–12 weeks from concept to first production batch, including formulation, stability testing, and packaging design. Rush orders for simple formulations can be completed in 4–6 weeks. We provide a detailed project plan upfront.

What certifications does SREKE hold, and are they verifiable?

We hold GMP certification (ISO 22716 and FDA 21 CFR 111), ISO 22000, and HACCP. Our certificates are available for download on our website and can be verified through the certification bodies. We also maintain full traceability through batch records and supplier audits.

Can SREKE help with regulatory compliance for US and EU markets?

Yes. Our regulatory team prepares all necessary documentation for FDA NDI notifications, EU Novel Food applications, and label reviews to ensure compliance with 21 CFR 101.93 and EFSA health claim regulations. We also provide support for customs clearance and import alerts.

Looking for a reliable OEM manufacturer for your supplement brand? SREKE provides GMP-certified custom formulation, private labeling, and contract manufacturing for softgels, capsules, tablets, powders, gummies, and liquids. Contact us at [email protected] or request a free quote — our team responds within 24 hours.